Related Experiment Video
Updated: May 27, 2026

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance
Published on: May 2, 2018
First report of mefA and msrA/msrB multidrug efflux pumps associated with blaTEM-1 β-lactamase in Enterococcus
Chedly Chouchani1, Allaaeddin El Salabi, Rim Marrakchi
1Université de Carthage, Institut Supérieur des Sciences et Technologies de l'Environnement de Borj-Cedria, Technopôle de Borj-Cedria, BP-1003, Hammam-Lif 2050, Tunisia. chdoula77@yahoo.fr
Objectives:
Enterococcus faecalis is thought to possess a great deal of intrinsic resistance to several antimicrobial agents. In this study we identified ampicillin- and erythromycin-resistant clinical isolates of E. faecalis and sought to identify the resistance mechanisms among these isolates.
Methods:
Twelve isolates of E. faecalis were collected from 12 different patients. Identification of the isolates and their susceptibility patterns were determined using the Phoenix automated phenotypic identification criteria. PCR amplification and sequencing were used to detect β-lactamase production. Colony blotting was performed in order to screen for multidrug efflux pump production. Extraction and N-terminal sequencing of the multidrug efflux pumps was carried out.
Results:
The E. faecalis isolates showed high resistance to erythromycin and ampicillin, with minimum inhibitory concentrations of >16 μg/ml. PCR amplification and sequencing showed that isolates produced TEM-1 β-lactamase. Colony blotting showed that these isolates harbored multidrug efflux pump genes. Multidrug efflux pump extraction, purification, and sequencing showed the distribution of mefA and msrA/msrB efflux pumps.
Conclusion:
Two resistance mechanisms among E. faecalis are described - the production of TEM β-lactamase and mefA and msrA/msrB efflux pumps. These results are of great interest because this is the first report of the co-existence of these resistance mechanisms among E. faecalis strains.
Insights
This study identified TEM-1 beta-lactamase and mefA/msrA/msrB efflux pumps as resistance mechanisms in clinical Enterococcus faecalis isolates. This is the first report of these two mechanisms co-existing in E. faecalis strains.
Area of Science:
- Microbiology
- Antimicrobial Resistance
- Molecular Biology
Background:
- Enterococcus faecalis exhibits significant intrinsic resistance to various antimicrobial agents.
- Understanding resistance mechanisms is crucial for effective treatment strategies.
Purpose of the Study:
- To identify ampicillin- and erythromycin-resistant clinical isolates of E. faecalis.
- To elucidate the specific resistance mechanisms employed by these isolates.
Main Methods:
- Phenotypic identification and susceptibility testing using the Phoenix automated system.
- PCR amplification and sequencing for beta-lactamase detection.
- Colony blotting and protein sequencing to identify multidrug efflux pumps.
Main Results:
- All E. faecalis isolates demonstrated high resistance to erythromycin and ampicillin (MIC >16 μg/ml).
- TEM-1 beta-lactamase production was confirmed via PCR and sequencing.
- The mefA and msrA/msrB efflux pumps were identified as contributing to multidrug resistance.
Conclusions:
- The study identified TEM-1 beta-lactamase and mefA/msrA/msrB efflux pumps as key resistance mechanisms in E. faecalis.
- This is the first documented instance of the co-existence of these two resistance mechanisms in E. faecalis strains.
- These findings highlight the evolving resistance landscape of E. faecalis.
More Related Videos
05:06Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance